Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...
CRB-701 Nectin-4 targeting ADC demonstrates encouraging results in Phase 1 Western study Fast Track Designation granted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback